Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

CBL , CBLB , TET2 , ASXL1 , and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia

Hideki Makishima, Anna M. Jankowska, Michael A. McDevitt, Christine O'Keefe, Simon Dujardin, Heather Cazzolli, Bartlomiej Przychodzen, Courtney Prince, John Nicoll, Harish Siddaiah, Mohammed Shaik, Hadrian Szpurka, Eric Hsi, Anjali Advani, Ronald Paquette, Jaroslaw P. Maciejewski

Blood (2011) 117 (21): e198–e206.

https://doi.org/10.1182/blood-2010-06-292433

Published: 2011

Includes: Supplemental data

Journal Articles

CBL, CBLB, TET2, ASXL1 , and IDH1/2 Mutations as Well as Additional Chromosomal Aberrations Constitute Molecular Events Contributing to Malignant Progression In Advanced Philadelphia Chromosome-Positive Disorders.

Hideki Makishima, MD, PhD, Anna Jankowska, MSC, Michael A McDevitt, MD, PhD, Simon Dujardin, Heather Cazzolli, Bartlomiej Przychodzen, Courtney Prince, John Nicoll, Siddaiah Harish, MD, Mohammed Shaik, MD, Eric Hsi, MD, Anjali Advani, MD, Ronald Paquette, MD, Jaroslaw P Maciejewski, MD, PhD, FACP

Blood (2010) 116 (21): 3396.

https://doi.org/10.1182/blood.V116.21.3396.3396

Published: 2010

Journal Articles

Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia

Hideki Muramatsu, Hideki Makishima, Anna M. Jankowska, Heather Cazzolli, Christine O'Keefe, Nao Yoshida, Yinyan Xu, Nobuhiro Nishio, Asahito Hama, Hiroshi Yagasaki, Yoshiyuki Takahashi, Koji Kato, Atsushi Manabe, Seiji Kojima, Jaroslaw P. Maciejewski

Blood (2010) 115 (10): 1969–1975.

https://doi.org/10.1182/blood-2009-06-226340

Published: 2010

Journal Articles

Cbl and TET2 Mutations Are Present in Refractory Ph+ Disorders Including Accelerated and Blast Crisis CML and ALL.

Hideki Makishima, MD, PhD, Anna M. Jankowska, Heather Cazzolli, Bartlomiej P Przychodzen, Courtney Prince, Siddaiah Harish, Heesun J. Rogers, MD, PhD, Eric D. Hsi, MD, Michael A McDevitt, MD, PhD, Anjali Advani, MD, Ronald Paquette, MD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 2173.

https://doi.org/10.1182/blood.V114.22.2173.2173

Published: 2009

Journal Articles

Impact of TET2 mutations On Responsiveness to Demethylating Agents in MDS.

Anna M. Jankowska, MSc, Mohammed Shaik, MD, Heather Cazzolli, Rebecca Ganetzky, B.A, Mikkael A. Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 1606.

https://doi.org/10.1182/blood.V114.22.1606.1606

Published: 2009

Journal Articles

C-Cbl but Not TET2 Mutations Are Present in Patients with Juvenile Myelomonocytic Leukemia.

Hideki Muramatsu, MD, Hideki Makishima, MD, PhD, Anna Malgorzata Jankowska, Heather Cazzolli, Christine O'Keefe, PhD, Nao Yoshida, MD, Yinyan Xu, Nobuhiro Nishio, Asahito Hama, Hiroshi Yagasaki, MD.PhD, Yoshiyuki Takahashi, Koji Kato, MD, Atsushi Manabe, Seiji Kojima, Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 420.

https://doi.org/10.1182/blood.V114.22.420.420

Published: 2009

Journal Articles

Molecular Lesions Associated with Loss of Heterozygosity Identified in CMML.

Anna M. Jankowska, MSc, Hideki Makishima, MD, PhD, Rebecca D Ganetzky, B.A., Monika Jasek, PhD, Heather Cazzolli, Courtney Prince, B.S., Manuel Afable, R.N., Christine O'Keefe, PhD, Ramon V. Tiu, MD, Heesun J. Rogers, MD, PhD, Eric D. Hsi, MD, Mikkael A. Sekeres, MD, MS, Michael A McDevitt, Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 416.

https://doi.org/10.1182/blood.V114.22.416.416

Published: 2009

Journal Articles

Permissive Conditions for Evolution of PNH Clones Are Characterized by Overproduction of IFN-γ by Clonal CD4 and CD8 T Cells, Fas-L by CTLs, and Promoted by Immunogenetic Background

Michael Clemente, Heather Cazzolli, Anna Jankowska, Christine O’Keefe, Bianca Serio, Susan Nyland, Marcin Wlodarski, PK Epling-Burnette, Thomas Loughran, Alan List, Ronald Paquette, Jaroslaw Maciejewski

Blood (2008) 112 (11): 4116.

https://doi.org/10.1182/blood.V112.11.4116.4116

Published: 2008

NARROW

CBL , CBLB , TET2 , ASXL1 , and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia

CBL, CBLB, TET2, ASXL1 , and IDH1/2 Mutations as Well as Additional Chromosomal Aberrations Constitute Molecular Events Contributing to Malignant Progression In Advanced Philadelphia Chromosome-Positive Disorders.

Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia

Cbl and TET2 Mutations Are Present in Refractory Ph+ Disorders Including Accelerated and Blast Crisis CML and ALL.

Impact of TET2 mutations On Responsiveness to Demethylating Agents in MDS.

C-Cbl but Not TET2 Mutations Are Present in Patients with Juvenile Myelomonocytic Leukemia.

Molecular Lesions Associated with Loss of Heterozygosity Identified in CMML.

Permissive Conditions for Evolution of PNH Clones Are Characterized by Overproduction of IFN-γ by Clonal CD4 and CD8 T Cells, Fas-L by CTLs, and Promoted by Immunogenetic Background

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only